Introduction
Transglutaminases (R-glutaminyl-peptide: amine y-glutamyltransferases, EC 2.3.2.13) catalyze an acyl transfer reaction in which the carboxamide group of a peptide-bound glutamine is the acyl donor and the primary amino group of a small-Mr amine or a peptide-bound lysine residue is the acyl acceptor (1-3). In the latter case, the enzyme covalently cross-links peptide chains through E(y-glutamy1)lysyl isopeptide bonds.
Transglutaminases are -SH enzymes with a cysteine at the active site, and can be classified as zymogenic and non-zymogenic types. The zymogenic protransglutaminases, a typical example of which is blood coagulation factor XI11 (FXIII), need proteolytic activation and Ca2+ to express their activity, whereas other transglutaminases assume an active configuration in the presence of Ca2+ without any proteolytic intervention. The most well-studied example of the latter group is tissue transglutaminase (transglutaminase C), which is present in a variety of cell types (e.g., endothelial cells, hepatocytes, red blood cells). The main function of transglutaminases is to form highly cross-linked protein polymers, such as cross-linked fibrin or the cornified envelope in epidermal cells.
Transglutaminase activity has been detected in the lenses of rabbit, calf, rat, guinea pig, and human cataract (4,5), and the elec-' Supported by grants OTKA F5469 and OTKA T16274 sule and the peripheral cortex on the posterior surface. Lens fibers were not stained with the antibodies. Factor XIII, another transglutaminase, could not be detected in the lens tissue. The localization of transglutaminase in the lens suggests that lens transglutaminase is synthesized in the epithelial cells and secreted into the virtual space between the capsule and the peripheral cortex spreading all around the lens substance. (JZfistochem Cytochem 43: [1173] [1174] [1175] [1176] [1177] 1995) KEY WORDS: Transglutaminase; Factor XIII; Western blotting; Immunohistochemistry; Human. trophoretic mobility of the enzyme suggested that it is of tissue transglutaminase type. The major lens proteins pand a-crystallins were found to be internal substrates for lens transglutaminase (4-U), and a possible role for lens transglutaminase in the process of terminal differentiation of lens fiber cells and cataractogenesis has been proposed (4,5,12,13). In the present study we showed that lens transglutaminase is immunologically related to but not identical with tissue transglutaminase and that it is localized in the epithelial cells on the anterior lens surface and also extracellularly in the virtual space between the capsule and the peripheral cortex.
Materials and Methods
Specimens. Seven non-cataractous (clear) human lenses were investigated. Three lenses were obtained from bulbs enucleated for intraocular tumor (age of patients 40. 41, 47 years), and four were cryoextracted because of traumatic luxation (age of patients 5 5 , 56, 57,64 years). The lenses were either frozen at -70°C or embedded in Tissue Tek OCT Compound (Miles; Elkhart, IN) in liquid nitrogen and stored at -7O'C.
Homogenization of Lenses. Lenses were homogenized in 2 ml50 mM HEPES buffer, pH 7.5, containing 100 mM CaCI, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 pglml benzamidine, 10 pglml leupeptin, and 100 Ulml aprotinin with a Teflon pestle-glass homogenizer immersed in crushed ice. Then, 1/10 volume of 10% Triton X-100 was added and the samples were sonicated three times for 30 sec on ice. Aliquots of lens homogenates were removed for protein determination, SDS-PAGE, transglutaminase assay, and immunoabsorption.
SDS-PAGE and
Immunoblotting. Human lens and human platelet homogenates were investigated for the presence of transglutaminase C and for FXIII subunit A (FXIIIA). To aliquots of lens homogenate (see above), 1 I HIDASI, ADhlY. MUSZBEK equal volumes of 2 x concentrated SDS-PAGE sample buffer (125 mM Tris-HCI, 4% SDS, 20% glycerol) containing 10% B-mercaptoethanol was added and the samples were boiled for 5 min. Human platelets were separated from anticoagulated blood and washed as described earlier (14) . The final platelet suspension was centrifuged (1300 x g, 15 min). The platelet pellet was sonicated in SDS-PAGE sample buffer containing 5% D-mercaptoethanol. boiled for 5 min. and the protein content determined.
The lens and platelet samples, as well as purified guinea pig liver tissue transgluraminase (obtained from Sigma Chemicals; St Louis. MO) and biotinylated Mr standard protein (Bio-Rad; Hercules, CA). were submitted to SDS-PAGE (15) using 7.5% gels. Four parallel runs of samples were electroblotted to Immobilon P membrane (Millipore; Bedford, MA). The membrane was cut into four pieces and each was blocked by 3% gelatin in 500 mM NaCI. 20 mM Tris-HCI. pH 7.5, for 1 hr at 37'C, then incubated for 30 min with one of the following antibodies: monoclonal mouse antibody against guinea pig liver transglutaminase (16); nonspecific mouse antibody of the same subclass specificity as the anti-transglutaminax antibody (kind gifts of Dr. Paul J. Birckbichler), both in 1:lOO dilution; rabbit antiserum against FXIIIA (Clotimmun-Factor XIIIA; Behringwerke AG, Marburg, Germany); and non-immune rabbit serum, both in 1:500 dilution. The antibodies were diluted in the same buffer as above. but the gelatin content was 1%. The membrane was washed in 0.05% Tween-20. 500 mM NaCI. 20 mM Tris-HCI. pH 7.5, three times for 10 min. The reaction for transgluraminase C and FXIIIA was detected by a highly sensitive technique using biotinylated anti-rabbit or anti-mouse IgG and avidin H-biorinylared horseradish peroxidase complex (Vecrasrain ABC kit; Vector Laboratories. Burlingame. CA). The instructions of the manufacturer were thoroughly followed, with the exception that the substrate solution contained 0.01% diaminobenzidine. 0.003% H202, and 0.006% CoCIz.
Immunoabsorption of Lens Transglutaminase. The entire procedure was carried out at 4'C. Two aliquots of strepravidin-agarose (Sigma), 0.3 ml each (50% gel content). were incubated with 42 pI(130 pg) biotinylated goat anti-mouse IgG for 20 min with continuous shaking. The strepravidin-agarose-biotinylated antibody complex was washed five times in 1.5 ml immunoprecipitation (IP) buffer, 50 mM HEPES, 100 mM NaCI. 0.1% Triton X-100. 1 mM PMSF, 10 pg/ml benzamidine. 10 pg/ml leupeptin. and 100 U/ml aprotinin, pH 7.5. One ml of lens homogenate (see above) was added to one of the tubes conraining the complex for nonspecific absorption and was incubated for 15 min with shaking. The agarose was removed by centrifugation, the supernatant was transferred to another tube, and 10 pl (30 pg protein) monoclonal anti-tissue transglutaminase antibody was added. After I-hr incubation the sample was mixed to the second tube of srreptavidin-agarose-biotinylated anti-mouse antibody complex and incubated for another 1 hr with constant shaking. After centrifugation the supernatant was removed for protein determination and transgluraminase assay.
Transglutaminase Assay. The determination of rransglutaminase activity was carried out essentially according to the filter paper assay of Lorand et al. (17) . In this assay, the incorporation of a small-M, radiolabeled amine substrate.
[ 'HI-putrescine (Amersham, Buckinghamshire, UK; 18.1 Ci/ mmol), into NN-dimethylared casein (Calbiochem; Lucerne, Switzerland) by transglutaminase is measured. Sixty pl lens homogenate. before or after immunoabsorprion. was incubated in an assay mixture (total volume 160 pl) containing the following components: 50 mM HEPES. pH 7.5. 100 mM NaCI. 0.5 mM dithiothreitol. 0.8 mM putrescine (200 pCilml). 0.5% N,N'dimerhylated casein, 5.0 mM CaC12 or. in the blanks, 6.5 mM EDTA. After incubation for 20.40. and 60 min ar 37"C, 10 pl of the reaction mixture was transferred onto 1-cm2 filter papef(Whatman 3M). To precipitate the proteins, the filter papers were immersed in 10% trichloroacetic acid (TCA) and rhen washed in 10% TCA for 20 min. in 5% K A three times for 5 min, in acetone-absolute ethanol (k1) for 5 min. and finally in acetone for 5 min under continuous stirring. The filter paper squares were dried. transferred into 2 ml Formula-989 scintillation fluid (DuPonr; Boston, MA). and the radioactivity covalently bound to casein was measured in a p-counter. Each experiment was carried out in duplicate. The results are calculated as the mean of the enzyme activities measured at the three intervals and were expressed as DPM radioactivity incorporated into caseinlmg lens protein.
Immunofluorescent Reactions. For single and double immunofluorescent reactions. 5-7-pm sections were cut in a Shandon minicryosrar (Bright Instrument: Astmoore. UK). wrapped in aluminium foil, and stored at -85°C. Immediately before use they were removed and left to reach room temperature (RT). All subsequent steps of immune reactions were carried out at RT. Sections were fixed in acetone for 10 min and after blocking with normal human serum for 15 min they were covered with undiluted mouse monoclonal anti-tissue rransgluraminase antibody or with 1:25 dilution of polyclonal goat antibody against guinea pig liver transglutaminase (a kind gift of Dr. Peter J.A. Davies) for 1 hr. Nonspecific mouse or goat immunoglobulin was used in negative controls. The sections were washed three times for 10 min. The reaction with the polyclonal antibody was developed with 1:lOO dilution of RE-labeled anti-goat rabbit antibody (Cappel: Malvern, PA) for 45 min. Biotinylated anti-mouse horse IgG (1:250 dilution: Vector) for 30 minutes and Texas Red-streptavidin (1:40 dilution: Amersham) for 45 min were used to visualize the reaction obtained with . Lane a, purified tissue transglutaminase from guinea pig liver (2 pg); Lane b, lens homogenate (400 pg protein). Proteins were separated by SDS-PAGE on 7.5% gel and electroblotted to Immobilon P membrane. The reaction was developed by a monoclonal mouse antibody against transglutaminase C. followed by biotinylated second antibody and avidin H-biotinylated peroxidase complex (see details in the text). No reaction was seen with platelet homogenate (400 pg protein) or when nonspecific mouse immunoglobulin replaced the monoclonal anti-transglutaminase antibody (not shown). on (A,B,D,E) the anterior surface and on (C) the posterior surface. Sections of the lens tissue were stained for tissue transglutaminase (A-D) and cytokeratin (E) as d e the monoclonal antibody. In double labeling reactions these steps were followed by the detection of cytokeratin, a marker protein of epithelial cells. The sections were incubated with a 1:10 dilution of rabbit anti-human pancytokeratin (Dako; Glostrup, Denmark) for 1 hr. After washing, the secondary reaction was developed by FIX-conjugated goat anti-rabbit IgG (Amersham) applied in 140 dilution for 30 min. PBS was used for antibody dilutions and in washing steps. After washing (three times for 5 min), the sections werc mounted with PBS-glyccrol(1:1) and evaluated by a fluorescence microscope equipped with an epifluorexencc condensor containing selective filters for F I T and Texv Red. The anti-transglutaminax antibodies gave no reaction with permeabilized platelets. which do not contain tissue transglutaminase (18) . whereas with vascular endothelial cells, a rich source of tissue transglutaminase. a positive reaction was obtained in tissue sections.
Results
The question of whether or not human lens transglutaminase is immunologically related to transglutaminase C (tissue transglutaminase) or FXIII was addressed by immunoblotting. using a wellcharacterized monoclonal antibody against guinea pig liver transglutaminase (16) and a monospecific rabbit antiserum against human FXIIIA. To detect any nonspecific reaction the immunoblotting experiments were also carried out with control mouse antibody of the same subclass specificity and with non-immune rabbit serum. Purified guinea pig liver transglutaminax and human platelet homogenate were used as positive control for tissue transglutaminase and FXIIIA, respectively. The monoclonal antitransglutaminase antibody reacted well with purified tissue transglutaminase, as demonstrated by a highly intense band on the immunoblot (Figure 1, lane a) . The mobility of this band corresponds to 78 KD, the Mr of tissue transglutaminase (2,3) . The anti-transglutaminase antibody also reacted with a lens protein of 86 KD (Figure 1, lane b) . This band was absent when nonspecific mouse immunoglobulin was used for immunodetection (not shown). The fact that a large amount of lens protein (400 pg) had to be applied to the gel to obtain a well-detectable reaction suggests that the concentration of transglutaminax in the entire lens is rather low. Using the same amount of proteins of human platelets, no reaction with the anti-tissue transglutaminase antibody was observed. No lens protein reacted with the antibody against FXIIIA although human platelet homogenate, a rich source of the potentially active A-subunit of FXIII, gave the expected positive reaction (not shown).
The assumption that the protein which reacted with the antibody against tissue transglutaminase is indeed lens transglutaminase was further supported by immunoabsorption experiment. The lens homogenate was immunoabsorbed by a monoclonal anti-transglutaminase antibody, biotinylated anti-mouse IgG antibody, streptavidin-agarose system. The transglutaminase activity in the lens homogenate was found 1482 DPM x mg-' x min-' (average of three determinations, all in duplicate), which decreased to 125 DPM x mg-' x min-' in the immunoabsorbed samples. This means scribed in the text. On the anterior surface, epithelial cells stain both for transglutaminase C and cytokeratin, whereas on the posterior surface a thin transglutaminasepositiw but cytokeratin-negative (not shown) stripe can be seen between the capsule and the peripheral cortex. Original magnifications: that 92% of the transglutaminase activity was absorbed from the lens homogenate by the monoclonal anti-tissue transglutaminase antibody. Nonspecific mouse immunoglobulin was without effect. No special attempt was made to identify the 8% transglutaminase activity that remained unabsorbed even at a saturating concentration of the antibody. It may represent another type of transglutaminase present in very low concentration or may be a proteolytic breakdown product from which the epitope reacting with the monoclonal antibody was removed but its enzymatic activity was stili retained.
The monoclonal antibody against tissue transglutaminase crossreacted with lens transglutaminase in immunohistochemical studies as well. Intense immunofluorescent staining for lens transglutaminase was observed just beneath the capsule all around the entire lens (Figure 2) . With polyclonal anti-tissue transglutaminase antibody, exactly the same staining pattern was observed, whereas no immunostaining was detected with non-immune mouse antibody or with a polyclonal antibody against FXIIIA (not shown). On the anterior surface the transglutaminase was present in the epithelial cell layer (Figures 2A and 2B) . The intense fluorescence appeared to have a cytoplasmic location. In double immunofluorescence studies, cytokeratin labeling appeared as a moderate but specific green fluorescence in the epithelial cell layer and appeared as a reaction completely overlapping with the transglutaminase staining ( Figures 2D and 2E) . On the posterior surface, the transglutaminase specific staining was confined to a thin, intense stripe between the lens capsule and the peripheral cortex (Figure 2C) . There was no labeling for cytokeratin over the transglutaminase deposition of the posterior surface.
Discussion
The experiments demonstrate that lens transglutaminase crossreacts with a monoclonal as well as with a polyclonal antibody against tissue transglutaminase but not with an antibody against FXIIIA. This finding is in agreement with an earlier report showing that lens transglutaminase in a non-denaturing agarose gel co-migrates with tissue transglutaminase but not with FXIII (4). Although immunologically related, lens transglutaminase does not appear to be identical to transglutaminase C which, as estimated by SDS-PAGE, has a somewhat lower molecular weight than the lens enzyme.
By immunofluorescence technique it was clearly demonstrated that lens transglutaminase was present both in the epithelial cells and extracellularly, beneath the lens capsule. These findings suggest that transglutaminase is synthesized in the epithelial cells, which then secrete it into the virtual space between the capsule and the peripheral cortex. The lens fibers did not appear to contain transglutaminase to any significant extent. Perhaps the enzyme becomes degraded proteolytically during the transformation of epithelial cells into fibers. It is possible that under pathological conditions, e.g., in human cataracts, transglutaminase-containing cellular elements also appear inside the lens tissue.
The physiological role of transglutaminase in the lens is not known, and at the present time only speculations can be offered. Transglutaminase is found in a subcapsular location all around the lens. The capsule is an elastic basement membrane, the thickest one in the human body, the components of which are secreted by the underlying epithelium. It serves as a metabolic barrier and is involved in the changes of lens shape during accommodation. It is extremely resistant to pathological insults. On this basis, it seems logical to propose that transglutaminase plays a role in organization and strengthening of the capsule by cross-linking its protein components. Because highly cross-linked proteins are extremely resistant to catabolic processes, it is possible that during the lifespan these cross-linked structures gradually accumulate, which leads to increased rigidity of the capsule and, eventually, to presbyopia. Clearly, further experiments are needed to test this intriguing hypothesis.
